EVALUATION OF SUBCONJUNCTIVAL MITOMYCIN- C, ONE MONTH BEFORE BARE SCLERA IN THE MANAGEMENT OF PRIMARY PROGRESSIVE PTERYGIUM
Dr. Kailas Chavan*, Dr. Amruta S. Pawar and Dr. Sushant Thorat
Purpose: Evaluation of subconjunctival mitomycin- C, one month before bare sclera in the management of primary progressive pterygium. Design: Prospective, randomized, interventional, hospital based study. Material & Methods: In present study 30 patients having primary progressive pterygium were randomly selected and they were treated with subconjunctival Mitomycin 1 month before bare sclera. All patients were followed up at one week, one month, three months, six months, twelve months and eighteen months post-operatively. A clinical photograph was taken at each follow-up visit. The major outcome measures were recurrence rate and complications if any. Results: Mean age of the patients in the study was 38.6 ± 12.6 years with males’ outnumbered females. Majority (70%) of patients were pursuing outdoor occupations. More (63%) number of patients were residing in rural area than urban area. Right eye had slight preponderance in the distribution of eyes. Maximum (90%) number of patients had pterygium on nasal side. Mean follow up period was 10.2±4.49 months. One patient (3.33%) had recurrence within study period. The surgical technique was not found to be associated with any serious vision threatening complications. Conclusion: Subconjunctival mitomycin C one month before bare sclera is simple, safe, economical, less time consuming, technically less demanding procedure and thus has potential to replace other methods of management of pterygium because of its simplicity, low recurrence rate and less complications.
Keywords: Pterygium, Fibrin glue, Mitomycin C.
[Full Text Article]